Table 1.
Patient demographic and clinical characteristics at baseline
| Characteristic | Total (N = 261) |
|---|---|
| Age (years) | 72.11 ± 10.39 |
| Age group | |
| ≤ 64 | 76 (29.12) |
| 65–74 | 73 (27.97) |
| 75–84 | 82 (31.42) |
| ≥ 85 | 30 (11.49) |
| Plan type | |
| Medicare | 184 (70.50) |
| Commercial | 77 (29.50) |
| Plan | |
| Comprehensive | 110 (42.15) |
| PPO/EPO | 94 (36.02) |
| HMO | 26 (9.96) |
| POS/POS with capitation | 19 (7.28) |
| CDHP/HDHP | 7 (2.68) |
| Missing/unknown | 5 (1.92) |
| Region | |
| Northeast | 41 (15.71) |
| North central | 89 (34.10) |
| South | 93 (35.63) |
| West | 38 (14.56) |
| Klabunde comorbidity score | 0.6 ± 0.75 |
| Klabunde comorbidity categories | |
| 0 | 100 (38.31) |
| 1 | 101 (38.70) |
| > 1 | 60 (22.99) |
| Castration (baseline) | |
| Medical | 260 (99.62) |
| Surgical | 1 (0.38) |
| Surgical and medical | 0 (0) |
| Metastases type | |
| Bone only | 207 (79.31) |
| Visceral only | 16 (6.13) |
| Lymph only | 28 (10.73) |
| Bone and visceral only | 5 (1.92) |
| Bone and lymph only | 5 (1.92) |
Data are presented as mean ± standard deviation or N (%) unless otherwise indicated
CDHP consumer-driven health plan, EPO exclusive provider organization, HDHP high-deductible health plan, HMO health maintenance organization, POS point of service, PPO preferred provider organization, SD standard deviation